Labopharm Inc.
Symbol:
DDS
Exchange:
TSX
Industry:
Consumer Products
Products:
Biotechnology/Pharmaceuticals
Company Website: Click Here
Company Info: Click Here
Quote and News: Click Here
Profiled Price:
$1.96
(August 14)
Company Snapshot:
Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets and Australia. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review in the U.S. by the FDA. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products.
|
